Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Real Estate · BNY Mellon / Dreyfus

BNY Mellon Developed Markets Real Estate Securities Fund Class A (DRLAX)

Ticker DRLAX · · Holdings as of Jul 31, 2026

Expense ratio
1.3%$130/yr per $10k
5-yr return
+3.0%annualized
1-yr return
+2.6%as of Dec 2025
Net assets
$340.5Mall share classes
Holdings
108

Bottom line

Is DRLAX a good fund? The bottom line

DRLAX is the Class A share class of BNY Mellon Developed Markets Real Estate Securities Fund, an actively managed real estate mutual fund from BNY Mellon / Dreyfus.

Annual fees run 1.3% — about $130 a year on every $10,000 invested, more expensive than 76% of real estate funds we track.

It returned +2.6% over one year, +3.0% a year over five years, +4.3% a year over ten (as of Dec 31, 2025, per its prospectus).

With $341 million in net assets and 108 holdings, its largest position is Welltower Inc (7.1%) and the top 10 make up 37.1% of the portfolio.

This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.

The closest lower-cost alternative we found is SCHH (0.07%, 56% top-holdings overlap).

What to watch

  • Expensive for its category (1.3%)
  • Front-end sales load up to 5.75%

Updated Nov 19, 2026

What DRLAX invests in

The fund seeks to maximize total return consisting of capital appreciation and current income.

To pursue its goal, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in publicly-traded equity securities of companies principally engaged in the real estate sector. The fund normally invests in a global portfolio of equity securities of real estate companies, including real estate investment trusts (REITs) and real estate operating companies, with principal places of business located in, but not limited to, the developed markets of Europe, Australia, Asia and North America (including the United States). In selecting investments for the fund's portfolio, CenterSquare Investment Management LLC (CenterSquare), the fund's sub-adviser, uses a proprietary approach to quantify investment opportunity from both a real estate and stock perspective. Generally, CenterSquare combines top-down real estate research and its relative value model…

From the fund's prospectus (filed Feb 26, 2026).

DRLAX performance

Fund calendar-year total returns, 2016–2025 2016: +4.2%; 2017: +11.1%; 2018: −5.0%; 2019: +22.8%; 2020: −2.8%; 2021: +26.6%; 2022: −23.4%; 2023: +12.2%; 2024: +3.7%; 2025: +8.9% +4% 2016 +11% 2017 −5% 2018 +23% 2019 −3% 2020 +27% 2021 −23% 2022 +12% 2023 +4% 2024 +9% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
DRLAX+2.6%+3.0%+4.3%
Real Estate median+2.6%+3.7%+4.5%

Source: Fund prospectus, as of Dec 31, 2025

Full DRLAX performance history →

What DRLAX costs

On a $10,000 investment, DRLAX's 1.3% expense ratio costs about $130 a year. The prospectus estimates $2,246 in total costs over 10 years (assuming 5% annual returns). The median real estate fund charges 0.95%.

See the full DRLAX fee table →

DRLAX top 10 holdings

#Holding% of fund
1Welltower Inc WELL7.06%
2Prologis Inc PLD5.93%
3Equinix Inc EQIX5.65%
4Digital Realty Trust Inc DLR4.00%
5Ventas Inc VTR3.45%
6Goodman Group GMG2.43%
7Brixmor Property Group Inc BRX2.36%
8Extra Space Storage Inc EXR2.33%
9Udr Inc UDR2.00%
10Public Storage PSA1.93%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 37.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to DRLAX

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
SchwabSCHH Schwab U.S. REIT ETF0.07%56% Compare
FidelityFSRNX Fidelity Real Estate Index Fund0.07%56% Compare
VanguardVRTPX Vanguard Real Estate II Index Fund0.08%56% Compare
J.P. MorganBBRE JPMorgan BetaBuilders MSCI US REIT ETF0.11%58% Compare
iSharesREET iShares Global REIT ETF0.14%64% Compare
DimensionalDFGR Dimensional Global Real Estate ETF0.22%60% Compare

More funds like DRLAX →

DRLAX FAQ

What is the expense ratio of DRLAX?
DRLAX's expense ratio is 1.3%, which works out to about $130 a year for every $10,000 invested. The prospectus estimates total costs of $2,246 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is DRLAX a good investment?
It depends on your goals, but the data points to: expensive for its category (1.3%); front-end sales load up to 5.75%. This is general information, not personalized advice.
What does DRLAX hold?
DRLAX's largest holdings are Welltower Inc (7.1%), Prologis Inc (5.9%), Equinix Inc (5.7%), Digital Realty Trust Inc (4.0%), Ventas Inc (3.4%). It holds 108 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is DRLAX's 5-year return?
DRLAX returned +3.0% a year over the five years ending Dec 31, 2025, and +4.3% a year over ten years. Past performance does not guarantee future results.
Does DRLAX have a sales load?
Yes. DRLAX has a maximum front-end sales charge of 5.75%.
What is a cheaper alternative to DRLAX?
SCHH (Schwab U.S. REIT ETF) overlaps about 56% with DRLAX and charges 0.07%.
Who manages DRLAX?
DRLAX is offered by BNY Mellon / Dreyfus through BNY Mellon Investment Funds V, Inc..